MyAverix Finance
US · Healthcare
Legend Biotech Corp (LEGN)
Biotechnology
Legend Biotech Corp (LEGN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LEGN
Legend Biotech Corp (LEGN) — FAQ
What is LEGN's P/E ratio?
The price-to-earnings (P/E) ratio for Legend Biotech Corp (LEGN) is 25.00 (data as of 2026-05-23).
Does Legend Biotech Corp pay a dividend?
Dividend yield is not available in the current snapshot for Legend Biotech Corp (LEGN). Check the MyAverix Finance app for the latest dividend data.
What sector is Legend Biotech Corp in?
Legend Biotech Corp (LEGN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LEGN listed on?
LEGN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.